Oğuz, S. H. Et Al. 2024. The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth. Endocrine , vol.84, no.1 , 287-292.

Oğuz, S. H., BOYRAZ, B. S., ERTÜRK, B., & YILDIZ, O. B., (2024). The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth. Endocrine , vol.84, no.1, 287-292.

Oğuz, Seda Et Al. "The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth," Endocrine , vol.84, no.1, 287-292, 2024

Oğuz, Seda H. Et Al. "The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth." Endocrine , vol.84, no.1, pp.287-292, 2024

Oğuz, S. H. Et Al. (2024) . "The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth." Endocrine , vol.84, no.1, pp.287-292.

@article{article, author={Seda Hanife Oğuz Et Al. }, title={The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth}, journal={Endocrine}, year=2024, pages={287-292} }